Brooke Rollins announced in Washington on Wednesday that the federal government is turning the traditional food pyramid upside down. The U.S. Secretary of Agriculture said the new guidelines will encourage Americans to prioritize protein-rich meals, whole milk, and saturated fats while limiting refined carbohydrates. “Our goal is to get Americans away from the highly processed packaged foods,” Rollins told reporters on Thursday, citing the obesity epidemic as the primary driver of the shift.

While the Department of Agriculture calls for a return to “real food,” the pharmaceutical industry is tightening its grip on the chemicals used to treat the symptoms of the modern diet. A federal judge in California recently ruled that Eli Lilly & Co. can proceed with a lawsuit against Mochi Health Corp. for selling copycat versions of its obesity and diabetes drugs. Eli Lilly argues that these compounded versions of tirzepatide harm the perception of their FDA-approved medications.

At the same time, health regulators are recommending new specialized treatments like Eli Lilly’s cancer pill, Jaypirca, for patients who have exhausted other options. This paper's reading: the state is attempting to fix the nation's biology through dietary advice while simultaneously defending the corporate monopolies that gate-keep the medicine required to treat the damage already done. The metabolic divide is widening; as generic semaglutide flows for $15 in the Global South, American patients remain trapped behind a mahogany courtroom bench of patent litigation and high-cost subscriptions.